Killer immunoglobulin-like receptor and human leukocyte antigen-C genotypes in rheumatoid arthritis primary responders and non-responders to anti-TNF-α therapy. [electronic resource]
Producer: 20121207Description: 1647-53 p. digitalISSN:- 1437-160X
- Adalimumab
- Adult
- Aged
- Antibodies, Monoclonal -- therapeutic use
- Antibodies, Monoclonal, Humanized -- therapeutic use
- Antirheumatic Agents -- therapeutic use
- Arthritis, Rheumatoid -- diagnosis
- Case-Control Studies
- Chi-Square Distribution
- Etanercept
- Female
- HLA-C Antigens -- genetics
- Heterozygote
- Homozygote
- Humans
- Immunoglobulin G -- therapeutic use
- Infliximab
- Male
- Middle Aged
- Northern Ireland
- Patient Selection
- Pharmacogenetics
- Phenotype
- Polymerase Chain Reaction
- Precision Medicine
- Receptors, KIR -- genetics
- Receptors, KIR2DL2 -- genetics
- Receptors, Tumor Necrosis Factor -- therapeutic use
- Risk Assessment
- Risk Factors
- Severity of Illness Index
- Time Factors
- Treatment Failure
- Tumor Necrosis Factor-alpha -- antagonists & inhibitors
No physical items for this record
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.